Hubei Biocause Heilen Pharmaceutical Co., Ltd. at its AGM held on May 14, 2024, approved 2023 profit distribution plan as follows: Cash dividend/10 shares (tax included): CNY 4.80000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.52 CNY | -2.02% | +3.27% | -33.24% |
1st Jan change | Capi. | |
---|---|---|
-33.24% | 576M | |
+63.05% | 856B | |
+39.45% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.48% | 234B | |
+16.47% | 226B | |
+14.63% | 177B | |
+1.08% | 165B |
- Stock Market
- Equities
- 301211 Stock
- News Hubei Biocause Heilen Pharmaceutical Co., Ltd.
- Hubei Biocause Heilen Pharmaceutical Co., Ltd. Approves Dividend for the Year 2023